Alyeska Investment Group’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.6M | Sell |
3,012,187
-1,047,577
| -26% | -$6.81M | 0.07% | 281 |
|
|
2025
Q1 | $32.2M | Buy |
4,059,764
+1,547,577
| +62% | +$12.3M | 0.13% | 193 |
|
|
2024
Q4 | $31.8M | Buy |
+2,512,187
| New | +$31.8M | 0.12% | 200 |
|
|
2024
Q1 | – | Sell |
-390,167
| Closed | -$5.7M | – | 478 |
|
|
2023
Q4 | $5.7M | Hold |
390,167
| – | – | 0.04% | 295 |
|
|
2023
Q3 | $4.79M | Hold |
390,167
| – | – | 0.03% | 337 |
|
|
2023
Q2 | $4.66M | Buy |
390,167
+125,000
| +47% | +$1.49M | 0.03% | 326 |
|
|
2023
Q1 | $3.55M | Buy |
265,167
+121,949
| +85% | +$1.63M | 0.03% | 312 |
|
|
2022
Q4 | $3.08M | Buy |
143,218
+1,075
| +0.8% | +$23.1K | 0.03% | 291 |
|
|
2022
Q3 | $2.85M | Sell |
142,143
-75,000
| -35% | -$1.5M | 0.03% | 293 |
|
|
2022
Q2 | $3.89M | Buy |
217,143
+113,943
| +110% | +$2.04M | 0.04% | 325 |
|
|
2022
Q1 | $1.02M | Hold |
103,200
| – | – | 0.01% | 492 |
|
|
2021
Q4 | $1.74M | Hold |
103,200
| – | – | 0.02% | 461 |
|
|
2021
Q3 | $2.45M | Hold |
103,200
| – | – | 0.03% | 470 |
|
|
2021
Q2 | $2.35M | Buy |
+103,200
| New | +$2.35M | 0.03% | 491 |
|